Omen Trio 20/12.5 Tablet is a combination of three medicines: Olmesartan, Cilnidipine and Chlorthalidone. Olmesartan is an angiotensin receptor blocker (ARB) and Cilnidipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Chlorthalidone is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
Taking Chlorthalidone with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Omen Trio 20/12.5 Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
No information is available on the use of Omen Trio 20/12.5 Tablet during lactation. Please consult your doctor.
Omen Trio 20/12.5 Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Omen Trio 20/12.5 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Omen Trio 20/12.5 Tablet may be needed. Please consult your doctor. Use of Omen Trio 20/12.5 Tablet is not recommended in these patients.
Omen Trio 20/12.5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Omen Trio 20/12.5 Tablet may be needed. Please consult your doctor. Use of Omen Trio 20/12.5 Tablet is not recommended in patients with severe liver disease.